EPCAM and cancer: The CAR-expressing iNK cells exhibited the antigen-dependent cytotoxicity against EpCAM-positive tumours cells, but not against EpCAM-positive normal cells, demonstrating to be a safe CAR-effector cell source for immunotherapy against cancer.